GD
Grandfield & Dodd Portfolio holdings
AUM
$1.71B
This Quarter Return
+7.42%
1 Year Return
+14.85%
3 Year Return
+57.47%
5 Year Return
+112%
10 Year Return
+284.72%
AUM
$1.45B
AUM Growth
+$86.1M
(+6.3%)
Cap. Flow
-$6.79M
Cap. Flow
% of AUM
-0.47%
Top 10 Holdings %
Top 10 Hldgs %
31.49%
Holding
200
New
11
Increased
56
Reduced
74
Closed
5
Top Buys
| 1 |
GE HealthCare
GEHC
|
$5.88M |
| 2 |
Hormel Foods
HRL
|
$4.12M |
| 3 |
Mettler-Toledo International
MTD
|
$3.95M |
| 4 |
Diageo
DEO
|
$3.66M |
| 5 |
Albemarle
ALB
|
$3.64M |
Top Sells
| 1 |
US Bancorp
USB
|
$8.67M |
| 2 |
M&T Bank
MTB
|
$8.43M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
$7.82M |
| 4 |
John Wiley & Sons Class A
WLY
|
$4.46M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$3.21M |
Sector Composition
| 1 | Technology | 28.85% |
| 2 | Healthcare | 18.49% |
| 3 | Industrials | 15.05% |
| 4 | Financials | 9.07% |
| 5 | Materials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Incyte
INCY
$17B
| $1.15M | 0.08% |
18,390
+319
| +2% | +$20K |
|
102
McDonald's
MCD
$226B
| $1.14M | 0.08% |
3,828
-99
| -3% | -$29.4K |
|
103
Hubbell
HUBB
$22.8B
| $1.04M | 0.07% |
3,147
| – | – |
|
104
H.B. Fuller
FUL
$3.18B
| $985K | 0.07% |
12,094
| – | – |
|
105
iShares Russell 1000 ETF
IWB
$43.1B
| $976K | 0.07% |
3,723
| – | – |
|
106
Waters Corp
WAT
$17.3B
| $958K | 0.07% |
2,910
| – | – |
|
107
Visa
V
$681B
| $923K | 0.06% |
3,544
-310
| -8% | -$80.7K |
|
108
AbbVie
ABBV
$374B
| $914K | 0.06% |
5,895
| – | – |
|
109
Jacobs Solutions
J
$17.1B
| $877K | 0.06% |
8,169
| – | – |
|
110
NVIDIA
NVDA
$4.15T
| $841K | 0.06% |
16,980
-1,620
| -9% | -$80.2K |
|
111
Kimberly-Clark
KMB
$42.5B
| $830K | 0.06% |
6,830
| – | – |
|
112
Genmab
GMAB
$16.7B
| $814K | 0.06% |
25,558
+565
| +2% | +$18K |
|
113
Tesla
TSLA
$1.08T
| $805K | 0.06% |
3,240
-140
| -4% | -$34.8K |
|
114
Vanguard Health Care ETF
VHT
$15.5B
| $763K | 0.05% |
3,045
| – | – |
|
115
Vanguard FTSE Pacific ETF
VPL
$7.7B
| $761K | 0.05% |
10,570
+400
| +4% | +$28.8K |
|
116
Becton Dickinson
BDX
$54.3B
| $743K | 0.05% |
3,049
-32
| -1% | -$7.8K |
|
117
3M
MMM
$81B
| $741K | 0.05% |
8,110
-3,166
| -28% | -$289K |
|
118
Bristol-Myers Squibb
BMY
$96.7B
| $726K | 0.05% |
14,140
+91
| +0.6% | +$4.67K |
|
119
West Pharmaceutical
WST
$17.9B
| $711K | 0.05% |
2,018
| – | – |
|
120
Eaton
ETN
$134B
| $687K | 0.05% |
2,854
| – | – |
|
121
Target
TGT
$42B
| $686K | 0.05% |
4,816
| – | – |
|
122
iShares National Muni Bond ETF
MUB
$38.6B
| $684K | 0.05% |
6,312
| – | – |
|
123
BP
BP
$88.8B
| $671K | 0.05% |
18,968
-359
| -2% | -$12.7K |
|
124
AstraZeneca
AZN
$255B
| $659K | 0.05% |
9,782
-1,055
| -10% | -$71.1K |
|
125
Philip Morris
PM
$254B
| $651K | 0.05% |
6,924
| – | – |
|